T1	Entity 159 173	p53 regulation
T2	KeyEntity 204 213	p53 locus
T3	Entity 220 244	homologous recombination
T4	Entity 248 256	ES cells
T5	KeyEntity 385 394	p53 locus
T7	KeyEntity 421 466	Recombinase-Mediated Cassette Exchange (RMCE)
T8	Entity 506 527	targeting in ES cells
T9	Entity 612 676	Adapted for targeting in Somatic cells to Accelerate Phenotyping
T10	KeyEntity 683 687	ASAP
T11	KeyEntity 678 687	RMCE-ASAP
T12	Entity 756 790	efficient targeting in fibroblasts
T13	Entity 796 821	rapid phenotypic read-out
T14	Entity 827 844	recessive mutatio
T15	Entity 871 880	RMCE-ASAP
T16	Entity 890 936	inverted heterologous recombinase target sites
T17	Entity 940 974	positive/negative selection marker
T18	Entity 994 1011	germline capacity
T19	Entity 1015 1023	ES cells
R1	regulates Arg1:T1 Arg2:T2	
R2	interacts_with Arg1:T3 Arg2:T4	
R4	other_relation Arg1:T10 Arg2:T9	
#2	AnnotatorNotes R4	is
R5	participates_in Arg1:T15 Arg2:T16	
R6	is_subclass_of Arg1:T16 Arg2:T17	
R7	is_part_of Arg1:T18 Arg2:T19	
T20	Entity 1042 1056	mouse genetics
R8	participates_in Arg1:T15 Arg2:T20	
T21	KeyEntity 1145 1148	p53
T22	KeyEntity 1473 1482	p53 locus
T23	Entity 1489 1513	homologous recombination
T24	Entity 1517 1536	embryonic stem (ES)
T25	Entity 1701 1732	physiological expression levels
T26	Entity 1671 1690	endogenous promoter
T27	KeyEntity 2021 2035	p53 regulation
T28	Entity 1967 1983	multiple tissues
R9	is_part_of Arg1:T27 Arg2:T28	
#3	AnnotatorNotes T23	experimental_procedure
T29	Entity 2818 2838	targeting efficiency
T30	Entity 2842 2850	ES cells
T31	KeyEntity 3495 3504	p53 locus
T32	Entity 3513 3521	ES cells
T33	Entity 3526 3537	fibroblasts
T34	KeyEntity 3539 3584	Recombinase-Mediated Cassette Exchange (RMCE)
T6	Entity 3622 3642	targeting efficiency
T35	Entity 3713 3739	selection cassette flanked
T36	Entity 3743 3767	recombinase target sites
T37	Entity 3789 3804	Cre recombinase
T38	Entity 3841 3867	Cre-mediated recombination
T39	Entity 3966 3989	inserts the mutant gene
#1	AnnotatorNotes T38	experimental_procedure
R3	participates_in Arg1:T38 Arg2:T39	
R10	participates_in Arg1:T34 Arg2:T6	
T40	Entity 4455 4507	marker enabling selection of the desired recombinant
T41	Entity 4744 4776	inverted heterologous loxP sites
T42	KeyEntity 4726 4730	RMCE
R11	is_part_of Arg1:T41 Arg2:T42	
T43	Entity 4889 4907	positive selection
T44	Entity 4924 4943	initial recombinant
R12	is_part_of Arg1:T43 Arg2:T44	
T45	Entity 4953 4971	negative selection
T46	Entity 4984 5004	‘marker-free’ mutant
R13	is_part_of Arg1:T45 Arg2:T46	
T47	Entity 5024 5040	RMCE experiments
T48	Entity 5064 5076	random sites
T49	Entity 5080 5098	somatic cell lines
R14	interacts_with Arg1:T47 Arg2:T48	
R15	is_part_of Arg1:T48 Arg2:T49	
T50	KeyEntity 5181 5185	RMCE
T51	Entity 5214 5239	selectable marker (15–17)
R16	regulates Arg1:T50 Arg2:T51	
T52	KeyEntity 5554 5558	RMCE
T53	Entity 5615 5647	inverted heterologous loxP sites
T54	Entity 5651 5685	positive/negative selection marker
R17	participates_in Arg1:T52 Arg2:T53	
R18	participates_in Arg1:T52 Arg2:T54	
T55	Entity 5987 6033	Somatic cells to Accelerate Phenotyping (ASAP)
T56	Entity 6633 6656	loxP257 spacer sequence
T57	KeyEntity 6742 6755	accurate RMCE
R19	participates_in Arg1:T56 Arg2:T57	
T58	Entity 7053 7068	puroΔTK plasmid
T59	Entity 7115 7131	oligonucleotides
T60	Entity 7145 7165	NotI site downstream
T61	Entity 7173 7185	puroΔTK gene
T62	Entity 7202 7220	NotI site upstream
T63	Entity 7228 7248	FseI site downstream
T64	Entity 7563 7588	5.5 kb ClaI-EagI fragment
T65	Entity 7933 7951	three-way ligation
T66	Entity 8643 8655	Plasmid Flox
T67	Entity 8671 8690	targeting construct
R20	is_part_of Arg1:T67 Arg2:T66	
T68	KeyEntity 8962 8984	p53-GFP fusion protein
T69	Entity 9007 9029	SacII-HindIII fragment
T70	Entity 9037 9046	p53 locus
T71	Entity 9123 9126	pBS
T72	Entity 9145 9157	HindIII site
T73	Entity 9165 9174	FseI site
T74	Entity 9555 9565	EcoRI site
R21	is_subclass_of Arg1:T69 Arg2:T70	
R22	interacts_with Arg1:T72 Arg2:T73	
T75	Entity 9640 9645	BamHI
T76	Entity 9650 9655	EcoRI
T77	Entity 9697 9718	Bam HI-EcoRI fragment
T78	Entity 9730 9752	phr-GFP-1 (Stratagene)
T79	Entity 10295 10305	PuΔTK gene
T80	KeyEntity 10475 10479	RMCE
T81	KeyEntity 10485 10491	p53GFP
T82	Entity 10495 10503	p53ΔPGFP
T83	Entity 11077 11089	Primary MEFs
T84	Entity 11105 11121	13.5 day embryos
R23	participates_in Arg1:T83 Arg2:T84	
#4	AnnotatorNotes R23	time stage
T85	Entity 11140 11144	DMEM
T86	Entity 11558 11572	Flox construct
T87	Entity 11589 11593	PmeI
T88	Entity 11599 11625	puromycin resistant clones
T89	Entity 12212 12215	PCR
#5	AnnotatorNotes T89	experimental_test
T90	Entity 12220 12228	Southern
#6	AnnotatorNotes T90	experimental_test
T91	Entity 12311 12320	puromycin
T92	Entity 12497 12501	FIAU
T93	Entity 12505 12516	ganciclovir
T94	Entity 13502 13524	p53 (CM-5, Novacastra)
T95	Entity 13529 13543	-actin (Sigma)
T96	Entity 13579 13620	peroxidase-conjugated goat anti-mouse IgG
T97	Entity 13625 13649	anti-rabbit IgG (Pierce)
T98	Entity 13684 13739	Pierce Supersignal West Pico chemiluminescent substrate
T99	Entity 13830 13848	60 Co γ-irradiator
T100	Entity 13912 13925	pulse-labeled
T101	Entity 13939 13943	BrdU
T102	Entity 13995 14009	FITC anti-BrdU
T103	Entity 14014 14030	propidium iodide
T104	Entity 14055 14079	Becton Dickinson FACScan
T105	Entity 14189 14198	RMCE-ASAP
T106	Entity 14261 14274	floxed allele
T107	Entity 14278 14286	ES cells
T108	Entity 14586 14590	RMCE
T109	Entity 14594 14602	ES cells
T110	Entity 14643 14668	p53 fused to GFP (p53GFP)
T111	Entity 14974 15039	1-(-2-deoxy-2-fluoro-1-b-d-arabino-furanosyl)-5-iodouracil (FIAU)
T112	Entity 15047 15054	TK loss
T113	Entity 15081 15084	PCR
#7	AnnotatorNotes T113	experimental_test
T114	Entity 15089 15102	Southern blot
#8	AnnotatorNotes T114	experimental_test
T115	Entity 15167 15192	very high RMCE efficiency
T116	Entity 15518 15531	p53 stability
T117	Entity 2053 2077	homologous recombination
T118	Entity 2081 2089	ES cells
T119	Entity 2171 2195	homologous recombination
T120	Entity 2427 2456	increase targeting efficiency
T121	Entity 2467 2496	breeding mice to homozygosity
T122	Entity 2916 2945	gene targeting in fibroblasts
T123	Entity 2990 3011	siRNAs in fibroblasts
T124	Entity 3228 3253	Targeting point mutations
T125	Entity 3257 3268	fibroblasts
T126	Entity 3272 3296	homologous recombination
T127	Entity 3389 3418	recessive autosomal mutations
T128	KeyEntity 4045 4049	RMCE
T129	Entity 4395 4399	RMCE
T130	Entity 4250 4254	loxP
T131	Entity 5705 5734	germline capacity of ES cells
T132	Entity 6363 6386	heterologous loxP sites
T133	Entity 6686 6693	WT loxP
T134	KeyEntity 6714 6718	RMCE
T135	Entity 7304 7329	PmlI-MfeI 6.3 kb fragment
T136	Entity 7335 7340	Trp53
T137	Entity 7369 7404	pBluescript KSII+ (pBS, Stratagene)
T138	Entity 7450 7454	SwaI
T139	Entity 7471 7475	EagI
T140	Entity 7493 7502	p53PmlEag
T141	Entity 7594 7603	p53PmlEag
R24	is_part_of Arg1:T135 Arg2:T136	
T142	Entity 7640 7644	ClaI
T143	Entity 7649 7653	NotI
T144	Entity 7703 7713	loxP sites
T145	Entity 7729 7733	ClaI
T146	Entity 7738 7742	FseI
T147	Entity 7765 7787	L3-p53PmlEagPuroΔTK-1L
T148	KeyEntity 7874 7882	p53 gene
T149	Entity 7971 7974	pBS
T150	Entity 7987 7994	HindIII
T151	Entity 7999 8003	NotI
T152	Entity 8007 8029	HindIII-EcoRI fragment
T153	Entity 8035 8040	Trp53
T154	Entity 8063 8082	EcoRI-NotI fragment
T155	Entity 8098 8106	DTA gene
T156	Entity 8113 8130	plasmid pgkdtabpa
T157	Entity 8177 8185	3′ + DTA
T158	Entity 8207 8219	Bsu36I-EcoRI
T159	Entity 8369 8377	3′ + DTA
T160	Entity 8409 8440	3.4 kb-long BamHI-PmlI fragment
T161	Entity 8458 8461	p53
T162	Entity 8483 8500	pBS (plasmid p5′)
T163	Entity 8618 8641	pSP72 plasmid (Promega)
T164	Entity 8793 8813	p53 coding sequences
T165	Entity 8877 8887	loxP sites
T166	Entity 9196 9211	C-terminal part
T167	KeyEntity 9219 9227	p53 gene
R25	is_part_of Arg1:T166 Arg2:T167	
T168	Entity 9245 9248	PCR
#9	AnnotatorNotes T168	experimental_test
T169	Entity 9787 9801	p53-GFP fusion
T170	Entity 9835 9865	L3-p53PmlEagPuroΔTK-1L plasmid
T171	Entity 9881 9888	HindIII
T172	Entity 9893 9897	FseI
T173	Entity 9926 9932	p53GFP
T174	Entity 10001 10009	p53ΔPGFP
T175	Entity 10076 10099	p53GFP exchange plasmid
T176	Entity 10123 10128	p53ΔP
T177	Entity 10327 10339	Flox plasmid
T178	KeyEntity 10409 10417	p53 gene
T179	Entity 10430 10444	Flox sequences
T180	Entity 10466 10470	Flox
T181	Entity 10555 10568	GFP sequences
T182	KeyEntity 10577 10581	RMCE
T183	KeyEntity 10587 10593	p53GFP
T184	Entity 10659 10662	p53
T185	KeyEntity 10738 10742	RMCE
T186	Entity 10718 10728	p53 intron
T187	Entity 10849 10862	WT p53 allele
T188	Entity 10984 10994	Neo marker
T189	Entity 11002 11015	p53 KO allele
T190	Entity 11154 11157	FBS
T191	Entity 11166 11169	BME
T192	Entity 11192 11203	antibiotics
T193	Entity 11176 11187	l-glutamine
T194	Entity 11205 11223	129/SvJae ES cells
T195	Entity 11277 11298	U/ml ESGRO (Chemicon)
T196	Entity 11314 11353	mitomycin C-treated SNLPuro-7/4 feeders
T197	Entity 11420 11429	puromycin
T198	Entity 11438 11442	FIAU
T199	Entity 11451 11462	ganciclovir
T200	Entity 11511 11528	29/SvJae ES cells
T201	Entity 11695 11706	blastocysts
T202	Entity 11832 11841	puromycin
T203	Entity 11878 11902	CMV-Cre plasmid (pOG231)
T204	Entity 11990 11994	FIAU
T205	Entity 12034 12049	electroporation
#10	AnnotatorNotes T205	experimental_test
T206	Entity 12271 12291	p53RMCE/− MEFs cells
T207	Entity 12356 12362	pOG231
T208	Entity 12772 12782	adriamycin
T209	Entity 12839 12843	Tris
T210	Entity 12859 12863	EDTA
T211	Entity 12872 12876	NaCl
T212	Entity 12883 12890	Nonidet
T213	Entity 12902 12906	PMSF
T214	Entity 12913 12928	sodium vanadate
T215	Entity 12936 12939	NaF
T216	Entity 12944 12997	Complete Mini Protease Inhibitors (Roche Diagnostics)
T217	Entity 13145 13169	Bio-Rad DC protein assay
T218	Entity 13215 13228	SDS/PAGE gels
#11	AnnotatorNotes T218	experimental_test
T219	Entity 13270 13297	poly(vinylidene difluoride)
T220	Entity 13352 13378	non-fat dried milk in TBST
T221	Entity 14346 14364	RMCE-ready ES cell
T222	Entity 14460 14493	12/300 puromycin-resistant clones
T223	Entity 14507 14520	Southern blot
#12	AnnotatorNotes T223	experimental_test
T224	Entity 14536 14539	PCR
#13	AnnotatorNotes T224	experimental_test
T225	Entity 14688 14691	p53
T226	Entity 14739 14755	GFP fluorescence
T227	KeyEntity 15200 15204	RMCE
T228	Entity 15270 15273	PCR
#14	AnnotatorNotes T228	experimental_test
T229	Entity 15278 15292	Southern blots
#15	AnnotatorNotes T229	experimental_test
T230	Entity 15342 15354	western blot
#16	AnnotatorNotes T230	experimental_test
T231	Entity 15306 15324	p53+/GFP ES clones
T232	Entity 15363 15383	antibody against p53
R26	is_part_of Arg1:T232 Arg2:T230	
T233	Entity 15478 15498	fusion of GFP to p53
R27	participates_in Arg1:T233 Arg2:T116	
T234	KeyEntity 15533 15562	steady-state levels of p53GFP
T235	Entity 15836 15847	blastocysts
T236	Entity 15801 15816	p53+/GFP clones
R28	participates_in Arg1:T236 Arg2:T235	
T237	Entity 15867 15890	pseudo-pregnant females
T238	Entity 15987 15998	p53 pathway
T239	Entity 16032 16034	ES
T240	Entity 16039 16052	somatic cells
T241	KeyEntity 16087 16097	p53 levels
T242	Entity 16102 16144	lack the p53-mediated DNA damage responses
T243	Entity 16054 16062	ES cells
R29	is_part_of Arg1:T242 Arg2:T243	
R30	is_part_of Arg1:T241 Arg2:T243	
T244	KeyEntity 16215 16218	p53
T245	Entity 16242 16261	mouse embryogenesis
R31	regulates Arg1:T245 Arg2:T244	
T246	Entity 16353 16374	high levels of p53GFP
T247	Entity 16382 16390	ES cells
T248	Entity 16405 16416	blastocysts
T249	Entity 16429 16466	revented normal embryonic development
R32	regulates Arg1:T246 Arg2:T249	
R33	is_part_of Arg1:T60 Arg2:T61	
R34	is_part_of Arg1:T77 Arg2:T78	
T250	Entity 7717 7725	L3-CF-1L
R35	is_part_of Arg1:T144 Arg2:T250	
R36	interacts_with Arg1:T79 Arg2:T177	
R37	interacts_with Arg1:T81 Arg2:T80	
R38	interacts_with Arg1:T81 Arg2:T180	
R39	interacts_with Arg1:T82 Arg2:T80	
R40	interacts_with Arg1:T82 Arg2:T180	
R41	interacts_with Arg1:T200 Arg2:T86	
R42	interacts_with Arg1:T87 Arg2:T86	
T251	Entity 12690 12702	DNA analysis
T252	Entity 13820 13822	RT
T253	Entity 13869 13871	Gy
R43	interacts_with Arg1:T252 Arg2:T99	
R44	interacts_with Arg1:T100 Arg2:T101	
T254	KeyEntity 16586 16590	RMCE
T255	KeyEntity 16598 16613	p53 fusion gene
T256	Entity 16627 16656	p53 proline-rich domain (PRD)
T257	Entity 16670 16675	p53ΔP
T258	Entity 16686 16691	p53ΔP
T259	Entity 16705 16708	GFP
T260	Entity 16781 16790	stability
T261	Entity 16807 16827	DNA-damage responses
T262	KeyEntity 16936 16940	RMCE
T263	Entity 16948 16976	p53ΔPGFP replacement plasmid
T264	Entity 16992 17001	efficient
T265	Entity 17006 17019	western blots
#17	AnnotatorNotes T265	experimental_test
T266	Entity 17090 17109	p53+/ΔPGFP ES cells
T267	Entity 17140 17152	PRD deletion
T268	Entity 17194 17202	p53ΔPGFP
T269	Entity 17212 17225	less abundant
T270	Entity 17231 17236	p53WT
T271	Entity 17244 17261	p53+/ΔPGFP clones
R45	is_part_of Arg1:T269 Arg2:T270	
T272	Entity 17471 17498	highly chimeric (>80%) mice
T273	Entity 17406 17435	Two p53+/ΔPGFP ES cell clones
T274	KeyEntity 17642 17646	RMCE
T275	Entity 17688 17709	germline transmission
R46	participates_in Arg1:T274 Arg2:T275	
T276	KeyEntity 17789 17793	RMCE
T277	Entity 17844 17854	p53 allele
T278	Entity 17919 17949	RMCE-ready p53 locus (p53RMCE)
T279	Entity 18002 18037	p53RMCE/+ chimeras with p53+/− mice
T280	Entity 18096 18110	p53RMCE/− MEFs
T281	KeyEntity 18136 18140	RMCE
T282	Entity 18148 18157	p53 locus
T283	Entity 18161 18174	somatic cells
R47	participates_in Arg1:T281 Arg2:T282	
T284	KeyEntity 18195 18199	RMCE
T285	Entity 18227 18241	p53RMCE/− MEFs
T286	Entity 18249 18271	Cre-expression plasmid
T287	Entity 18280 18294	p53GFP plasmid
R48	interacts_with Arg1:T285 Arg2:T286	
R49	interacts_with Arg1:T285 Arg2:T287	
T288	KeyEntity 18425 18429	RMCE
T289	Entity 18435 18441	p53GFP
R50	is_part_of Arg1:T289 Arg2:T288	
T290	Entity 18445 18453	ES cells
T291	KeyEntity 18466 18472	p53GFP
T292	Entity 18543 18554	p53 pathway
T293	Entity 18580 18584	MEFs
R51	regulates Arg1:T292 Arg2:T293	
T294	Entity 18659 18680	high levels of p53GFP
T295	Entity 18716 18729	toxic to MEFs
R52	participates_in Arg1:T294 Arg2:T295	
T296	Entity 18739 18743	MEFs
T297	Entity 18774 18795	failed to proliferate
R53	participates_in Arg1:T296 Arg2:T297	
T298	Entity 18955 18978	fluorescence microscopy
#18	AnnotatorNotes T298	experimental_test
T299	Entity 18823 18837	p53RMCE/− MEFs
T300	Entity 18843 18857	electroporated
T301	Entity 18867 18895	p53GFP replacement construct
T302	Entity 18904 18936	without a Cre-expression plasmid
T303	Entity 19217 19223	p53GFP
T304	Entity 19420 19442	‘fried-egg’ appearance
T305	Entity 19390 19407	fluorescent cells
R54	is_part_of Arg1:T304 Arg2:T305	
T306	KeyEntity 19588 19592	RMCE
T307	Entity 19610 19632	p53GFP-expressing MEFs
T308	Entity 19664 19679	p53GFP toxicity
R55	regulates Arg1:T306 Arg2:T307	
R56	participates_in Arg1:T307 Arg2:T308	
